6 - Diseases of Infancy and Childhood Flashcards
Congenital Anomalies (1 of 3): Malformations
Multifactorial-multiplie genetic loci involved
E.g. Polydactyly/syndactyly
Congenital Anomalies (2 of 3): Disruptions
Results from secondary destruction of an organ or body region
E.g. amniotic band
Congenital Anomalies (3 of 3): Syndrome
Constellation of congenital anomalies
Often caused by a single etiologic agent
e.g. viral infection of specific chromosomal abnormality
Congenital Anomalies: Deformations
Extrinsic developmental disturbance
Patogenesis: localized or generalized compression of the fetus –> leading to a variety of structural abnormalities
The most common cause: uterine constraint
Maternal factors: 1st pregnancy, small uterus, malformed uterus, leiomyomas
Fetal or placental factors: oligohydramnios, multiple fetuses, abnormal fetal presentation
Congenital Anomalies: Sequence
A cascade of anomalies triggered by one initiating aberration
E.g. the oligohydramnios or potter sequence
Prematurity:
Gestational age of less than 37 weeks
The second most common cause of neonatal mortality
Based on birth weight infants classified as
AGA: Appropriate for gestational age
SGA: Small for gestational age
LGA: Large for gestational age
Neonatal Respiratory Distress Syndrome
Also known as hyaline membrane disease is most common form
Due to deposition of hyaline proteinaceous materials in the peripheral airspaces
Neonatal Respiratory Distress Syndrome: Other Causes
Excessive sedation of the mother
Fetal head injury during delivery
Aspiration of blood or amniotic fluid
Intra-uterine hypoxia due to cord around neck
Neonatal Respiratory Distress Syndrome 2
Type II pneumocytes secrete surfactant (DPPC) and reduce alveolar surface tension
Deficiency of SFTPB or SFTBC genes –> congenital deficiency of surfactant
Atlectasis: collapse of lung (can lead to uneven perfusion)
Neonatal Respiratory Distress Syndrome: Clinical Findings (Slide 12)
Dyspnea, Cyanosis, bilateral fine rales
Chest x-ray: ground glass appearance of lungs
Neonatal Respiratory Distress Syndrome: Management
Investigation: By estimating the level of amniotic phospholipids
Treatment: Prophylactic administration of exogenous surfactant at birth
Antenatal corticosteroids to mothers with threatened premature delivery
Neonatal Respiratory Distress Syndrome: Complications (4)
- O2 Toxicity - O2 derived free radicals
- Bronchopulmonary dysplasia
- Retrolental fibroplasia - VEGF markedly decreased
- Infants who recover from RDS: At increased risk for PDA, intraventricular hemorrhage and NEC
Necrotising Enterocolitics (NEC)
Very common in premature infants
Multifactorial
Prematurity –> enteral feeding
Introduction of bacteria (Postnatal insult)
Sets in motion the cascade of events
Tissue destruction
NEC
No single pathogen linked to NEC
Inflammatory mediators: PAF increase mucosal permeability by inducing apoptosis of the enterocytes, and damaging zonula occludens or tight junctions in between the epithelial cells
Now that the mucosal barrier is down, the guy flora can invade transmurally, cause inflammation and mucosal necrosis –> further bacterial entry, sepsis and shock
NEC: Clinical Findings and Investigations
Clinical Findings:
Bloody stools
Abdominal Distention
Circulatory collapse
Investigations:
Stool and serum samples have higher levels of PAF as compared to age-matched controls
NEC: Gross Pathology
Terminal ileum, caecum, and right colon
Involved segment-distended, friable, and congested or even gangrenous. Gas bubbles
Perforation with peritonitis
Fetal Hydrops
Can be immune or non-immune
Immune: Hemolytic disease caused by blood group incompatibility between mother and fetus
Causes: Refer to table on Slide 20
Inborn Errors of Metabolism (3)
PKU, Galactosemia, Cystic Fibrosis
Mode of inheritance, genetic defect, biochemical abnormality, morphological changes seen in organs affected, clinical course of the disease
PKU
Autosomal Recessive Inheritance
Bi-allelic mutation
Deficient enzyme: Phenylalanine Hydroxylase System
Defect: Inability to convert phenylalanine to tyrosine –> Phenylalanine gets accumulated –> enters minor shunt pathways –> phenylpyruvic acid, penyllactic acid, and phenylacetic acid excretedin large amounts in the urine
PKU: Clinical Features
Normal at birth within few weeks raised PA
Brain damage: severe mental retardation
Seizures, can’t talk and walk
Decrease pigmentation of hair, skin, and eczema
PKU mother not on dietary restriction = baby with mental retardation, microcephalic, CHD
Early dx and dietary restriction of phenylalanine can prevent MR
Galactosemia
Autosomal Recessive
Deficient enzyme: Galactose-1-phosphate uridyl transferase (GALT)
Accumulation of major galactise-1-phosphate
Alternate metabolic pathway products - Galactitol, galactonate
Galactosemia: Clinical Features
Symptoms appear with milk ingestion in infants
Failure to thrive almost from birth, vomiting, and diarrhea
Cataracts within few weeks
Aminoaciduria
Jaundice, hepatomegaly within few days of milk ingestion
Mental retardation at 6-12 months
E.coli infection (depressed bactericidal activity of neutrophil)
Galactosemia: Pathology
Liver (fatty change and fibrosis)
Lens of eyes show opacities (Cataracts)
Brain damage involved (mechanism unknown) loss of neurons, gliosis, and edema
Galactosemia: Management
Investigation: Reducing sugar in urine and confirmed by GALT assay in tissue
Treatment: Removal of galactose from diet for at least the first 2 years of life
Cystic Fibrosis
Autosomal Recessive Inheritance
Widespread disorder in epithelial chloride transport affecting fluid secretion in:
- Exocrine glands
- Epithelial lining of the respiratory, GI, and reproductive tracts
- Abnormal viscid mucus secretion
Sweat test: Increased chloride and increased sodium
Cystic Fibrosis: CFTR Gene Structure and Activation
Two transmembrane spanning domains
Two cytoplasmic nucleotide binding domains
One R (Regulatory domain
Activation of CFTR done by Ach (agonist) induced regulation of chloride channel
Interacts with epithelial Na channels (EnAc)